Baillie Gifford & Co Portfolio holdings
Baillie Gifford & Co., founded in 1908 by Lt Col Augustus Baillie and Carlyle Gifford and headquartered in Edinburgh, Scotland, is an independent, partnership-owned investment management firm renowned for its long-term, growth-oriented approach, managing over £230 billion ($290 billion USD) in assets as of late 2024. Focusing primarily on global equities, the firm serves institutional clients like pension funds and retail investors through mutual funds and investment trusts, such as the Scottish Mortgage Investment Trust, emphasizing fundamental research into innovative, high-growth companies—often holding stakes in firms like Tesla and Amazon for decades. With around 2,000 employees across offices in London, New York, Hong Kong, and beyond, Baillie Gifford operates without external ownership pressures, allowing its 58 partners to prioritize patience and conviction over short-term market trends. Known for its low-profile culture and ESG integration, the firm has earned a reputation as a thoughtful, contrarian investor in a world of rapid-fire trading.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Datadog
DDOG
|
+$359M |
| 2 |
Cloudflare
NET
|
+$345M |
| 3 |
Mercado Libre
MELI
|
+$330M |
| 4 |
Amazon
AMZN
|
+$254M |
| 5 |
Joby Aviation
JOBY
|
+$239M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$573M |
| 2 |
Booking.com
BKNG
|
+$473M |
| 3 |
Netflix
NFLX
|
+$376M |
| 4 |
AXON
Axon Enterprise
AXON
|
+$373M |
| 5 |
Spotify
SPOT
|
+$336M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 27.39% |
| 2 | Technology | 24.37% |
| 3 | Healthcare | 18.87% |
| 4 | Communication Services | 12.6% |
| 5 | Financials | 6.11% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
226
Ascendis Pharma A/S
ASND
$16.8B
| $8.08M | 0.01% |
90,502
-1,191
| -1% | -$104K |
|
227
Burford Capital
BUR
$971M
| $7.84M | 0.01% |
643,107
-1,151,455
| -64% | -$14.9M |
|
228
FTI Consulting
FCN
$4.18B
| $7.67M | 0.01% |
40,323
-11,000
| -21% | -$2.08M |
|
229
Health Catalyst
HCAT
$128M
| $7.38M | 0.01% |
590,454
-11,309
| -2% | -$135K |
|
230
Fortive
FTV
$18.6B
| $7.31M | 0.01% |
129,799
| – | – |
|
|
NBTX
231
Nanobiotix
NBTX
$1.94B
| $7.25M | 0.01% |
1,400,000
| – | – |
|
|
TRHC
232
DELISTED
Tabula Rasa HealthCare, Inc. Common Stock
TRHC
| $6.86M | 0.01% |
831,278
| – | – |
|
233
dLocal
DLO
$4.24B
| $6.76M | 0.01% |
553,846
-204,048
| -27% | -$2.7M |
|
234
Nike
NKE
$61.9B
| $6.53M | 0.01% |
59,159
+59,069
| +65,632% | +$6.91M |
|
235
Globus Medical
GMED
$11.2B
| $6.53M | 0.01% |
109,660
-436
| -0.4% | -$24.8K |
|
236
Tandem Diabetes Care
TNDM
$1.56B
| $6.45M | 0.01% |
262,756
-187
| -0.1% | -$6.02K |
|
|
HUYA
237
Huya Inc
HUYA
$558M
| $6.32M | 0.01% |
1,765,711
| – | – |
|
238
EOG Resources
EOG
$70.7B
| $6.13M | 0.01% |
+53,557
| New | +$6.12M |
|
239
GitLab
GTLB
$6.58B
| $5.73M | ﹤0.01% |
112,179
-1,225
| -1% | -$45.5K |
|
240
Compañía de Cervecerías Unidas
CCU
$2.21B
| $5.44M | ﹤0.01% |
335,114
-22,786
| -6% | -$363K |
|
|
AKLI
241
DELISTED
Akili Inc
AKLI
| $5.18M | ﹤0.01% |
4,665,795
| – | – |
|
242
Relay Therapeutics
RLAY
$4.33B
| $5.17M | ﹤0.01% |
411,308
-4,355
| -1% | -$54.2K |
|
243
LivePerson
LPSN
$32.3M
| $4.66M | ﹤0.01% |
68,701
+328
| +0.5% | +$21.3K |
|
|
SAGE
244
DELISTED
Sage Therapeutics
SAGE
| $4.41M | ﹤0.01% |
93,719
-1,326
| -1% | -$66K |
|
245
NextEra Energy
NEE
$177B
| $4.15M | ﹤0.01% |
55,982
+4,466
| +9% | +$338K |
|
246
Freshpet
FRPT
$3.22B
| $4.12M | ﹤0.01% |
62,599
+54,413
| +665% | +$3.56M |
|
|
NCNA
247
NuCana
NCNA
$6.12M
| $2.89M | ﹤0.01% |
732
| – | – |
|
|
CLLS
248
Cellectis
CLLS
$285M
| $2.8M | ﹤0.01% |
1,418,996
-220,900
| -13% | -$424K |
|
249
Inspire Medical Systems
INSP
$1.74B
| $2.54M | ﹤0.01% |
7,829
+7,644
| +4,132% | +$2.18M |
|
250
MongoDB
MDB
$32.1B
| $2.45M | ﹤0.01% |
5,952
-287
| -5% | -$83.7K |
|
Similar funds
Baillie Gifford & Co's Q2 2023 Portfolio in Review
As of Q2 2023, Baillie Gifford & Co held 461 positions worth $118B, up 6.1% from $111B the previous quarter. Its ten largest holdings account for 41% of the portfolio.
Baillie Gifford & Co's Q2 2023 filing shows 7 new, 99 increased, 159 reduced and 164 closed positions. Its largest new stake was Yeti Holdings: 3,128,447 shares worth $122M. The largest sale was Tesla, an estimated $573M.
By sector, the portfolio is most concentrated in Consumer Discretionary at 27% of assets, down from 28% a quarter earlier, followed by Technology and Healthcare.
- Baillie Gifford & Co's largest Q2 2023 buy was Yeti Holdings: 3,128,447 shares worth $122M.
- Baillie Gifford & Co added most to Datadog in Q2 2023, an estimated $359M increase.
- Baillie Gifford & Co's biggest Q2 2023 reduction was Tesla, cutting an estimated $573M.
- Baillie Gifford & Co fully exited RB Global in Q2 2023, selling an estimated $86.6M.
- Baillie Gifford & Co's ten largest holdings make up 41% of its $118B portfolio in Q2 2023.
- Baillie Gifford & Co opened 7 new positions and closed 164 in Q2 2023.
- Baillie Gifford & Co's portfolio value rose 6.1% quarter-over-quarter to $118B.
Based on Baillie Gifford & Co's 13F filing for Q2 2023, filed 28 Jul 2023.